-
Forward Look
Fueling the Pediatric Cancer PipelineNew efforts are needed to push the pace of drug development.
by Leah Lawrence
-
Forward Look
It Takes a VillageImproving pediatric cancer care in developing countries
by Leah Lawrence
-
Forward Look
Identifying the Unexpected Risks of Targeted TherapyDrugs designed to single out cancer cells also may have side effects.
by Melissa Weber
-
Forward Look
Get Smart About Smartphone Cancer AppsStudy shows reasons to be skeptical about medical apps.
by Stephen Ornes
-
When Less Is MoreStudies are finding that aggressive treatment, such as extensive surgery, radiation or chemotherapy, is not always necessary for cancer patients to get good results.
by Alexandra Goho
-
No Through RoadCancer cells are able to find new pathways around targeted therapies. Scientists are racing to get there first.
by Sue Rochman
-
Healthy Habits
It Takes All KindsA variety of vegetables and fruit can help reduce your cancer risk
by Marci A. Landsmann
-
Healthy Habits
Follow the RainbowAdding colorful fruits and vegetables to your diet may reduce cancer risk.
by Stephen Ornes
-
Healthy Habits
Hang Up the Car KeysCut cancer risk by choosing to walk instead of drive.
by Stephen Ornes
-
Q&A
The Legacy of Henrietta LacksAuthor Rebecca Skloot reflects on the contributions of one woman to science and the importance of informed consent in human research.
by Alexandra Goho
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
